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Background: Medication nonadherence leads to suboptimal treatment outcomes, making it a major priority in health care.
eHealth provides an opportunity to offer medication adherence interventions with minimal effort from health care providers
whose time and resources are limited.
Objective: The aim of this systematic review is twofold: (1) to evaluate effectiveness of recently developed and tested interactive
eHealth (including mHealth) interventions on medication adherence in adult patients using long-term medication and (2) to
describe strategies among effective interventions.
Methods: MEDLINE, EMBASE, Cochrane Library, PsycINFO, and Web of Science were systematically searched from January
2014 to July 2019 as well as reference lists and citations of included articles. Eligible studies fulfilled the following inclusion
criteria: (1) randomized controlled trial with a usual care control group; (2) a total sample size of at least 50 adult patients using
long-term medication; (3) applying an interactive eHealth intervention aimed at the patient or patient’s caregiver; and (4) medication
adherence as primary outcome. Methodologic quality was assessed using the Cochrane risk of bias tool. Selection and quality
assessment of studies were performed by 2 researchers (BP and BvdB or JV) independently. A best evidence synthesis was
performed according to the Cochrane Back Review Group.
Results: Of the 9047 records screened, 22 randomized clinical trials were included reporting on 29 interventions. Most (21/29,
72%) interventions specified using a (mobile) phone for calling, SMS text messaging, or mobile apps. A majority of all interactive
interventions (17/29) had a statistically significant effect on medication adherence (P<.05). Of these interventions, 9 had at least
a small effect size (Cohen d ≥ 0.2) and 3 showed strong odds for becoming adherent in the intervention group (odds ratio > 2.0).
Our best evidence synthesis provided strong evidence for a positive effect of interventions using SMS text messages or interactive
voice response, mobile app, and calls as mode of providing adherence tele-feedback. Intervention strategies “to teach medication
management skills,” “to improve health care quality by coordinating medication adherence care between professionals,” and “to
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facilitate communication or decision making between patients and health care providers” also showed strong evidence for a
positive effect.
Conclusions: Overall, this review supports the hypothesis that interactive eHealth interventions can be effective in improving
medication adherence. Intervention strategies that improve patients’ treatment involvement and their medication management
skills are most promising and should be considered for implementation in practice.
(J Med Internet Res 2021;23(1):e18901) doi: 10.2196/18901
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Introduction
Long-term medication aims to reduce the risk of disease
progression, comorbidity, and mortality [1]. These outcomes
will only be reached when patients adhere to their medication.
Presumably 50% of all patients with long-term medication are
nonadherent, leading to suboptimal treatment outcomes [2,3].
Although improvement on clinical outcomes is the ultimate
treatment goal, measuring adherence to long-term medication
allows for comparison across chronic conditions.
Medication adherence is defined as the extent to which
medication taking behavior corresponds with the medication
regimen agreed upon with the health care professional [4].
Medication-taking behavior is influenced by different factors
such as experience, beliefs, and culture, making it multifaceted.
Moreover, medication-taking behavior can differ between each
drug and may change over time. Targeted, timely interventions
enhancing medication adherence have therefore become one of
the major priorities in health care. Despite efforts, randomized
controlled trials have demonstrated limited effectiveness of
medication-enhancing interventions [5-9]. Besides, effective
interventions differed markedly and did not apply similar
intervention strategies, making comparisons or meta-analysis
difficult [3,5-7].
eHealth might provide an opportunity to offer accessible,
interactive, timely, and feasible medication adherence
interventions that require minimal effort from health care
providers whose time and resources are limited. eHealth or
telemedicine—these words are used interchangeably—is defined
as the use of information and communication technology in
health care [10]. These technologies can facilitate tailored and
interactive solutions such as targeted education, consistent
support, and skill acquisition. Thus, the multifaceted and
versatile medication-taking behavior can well be targeted by
eHealth interventions.
eHealth seems a promising way forward but recent systematic
reviews showed conflicting results for eHealth interventions on
improving medication adherence [11-14]. These reviews focused
on single long-term conditions and have led to fragmented
knowledge on the effectiveness and strategies of eHealth
interventions. Evidence on eHealth interventions should be
clustered to comprehensively investigate effectiveness of
eHealth interventions and facilitate generalizability of study
findings. Sieben et al [5] and Linn et al [15] found promising
results across long-term conditions but the fast developments
in eHealth render those results outdated, their definition of
eHealth as “internet” was too narrow, and included studies had
methodological limitations. Therefore the aim of our systematic
review is twofold: (1) to evaluate effectiveness of recent
interactive eHealth interventions on medication adherence in
adult patients using long-term medication and (2) to describe
applied strategies within effective interventions.
Methods
This systematic review adheres to the PRISMA (Preferred
Reporting Items for Systematic Reviews and Meta-analyses)
statement [16] and was completed according to the registered
protocol PROSPERO 2019 CRD42019088873 [17].
Search Strategy and Study Selection
Searches were undertaken in MEDLINE, EMBASE, Cochrane
Library, PsycINFO, and Web of Science to identify eligible
studies. The search strategy comprised 3 blocks: eHealth,
medication adherence, and randomized clinical trial (see
Multimedia Appendix 1 for the MEDLINE search). Reference
lists and citations of included studies were checked to ensure
literature saturation. Titles and abstracts were screened and
full-text articles were assessed by 2 researchers (BP and BvdB
or BP and JV) independently based on the inclusion criteria
below. Discrepancies between researchers were resolved through
discussion or by reaching consensus with the third researcher
(BvdB or JV).
Eligibility Criteria
Eligible studies fulfilled the following inclusion criteria: (1)
randomized controlled trial with a usual care control group; (2)
applying an interactive eHealth intervention aimed at the patient
or patient’s caregiver; (3) medication adherence as primary
outcome; (4) a total sample size of at least 50 adult patients
using long-term medication as determined by Zwikker et al
[18]; and (5) published between 2014 and July 2019. Only
peer-reviewed English full-text articles were included. We
considered all interventions solely applied over distance as
eHealth interventions (eg, online portals, telephone calls).
Blended care interventions, where face-to-face contact is
combined with online components, were excluded. Interventions
were considered interactive if there was tele-feedback regardless
by whom on medication adherence (eg, bidirectional text
messaging, sending adherence reports). Only validated
medication adherence outcomes (ie, objective measures or
subjective measures that have been compared to objective
measures) were taken into account.
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Two researchers (BP and JV) independently assessed the internal
validity of included studies using the Cochrane Collaboration’s
tool for assessing risk of bias [19]. Seven domains were scored
as having low (+), high (–), or unclear (?) risk of bias. Because
blinding of participants and personnel is hardly feasible in
studies evaluating interventions aimed at adherence, this domain
was considered high risk (–) for all studies. Studies with a
positive score (+) on at least five domains were considered
high-quality studies. If relevant information was not reported,
the corresponding author was contacted to request additional
information. When no additional relevant information was
provided, the risk of bias domain was scored as unclear (?).
Data Extraction
A standardized template was made to extract data on study
characteristics, eHealth interventions, and medication adherence
outcomes. Details of the eHealth interventions were extracted
according to the Template for Intervention Description and
Replication (TIDieR) checklist [20]. Additionally, the mode of
adherence tele-feedback of each eHealth intervention was
extracted. We distinguished the following modes of adherence
tele-feedback: monitoring device, SMS text messaging,
interactive voice response (IVR), mobile app, call, or e-training.
Intervention strategies were categorized based on the strategies
defined by Lowe et al [21] to support behavior change (ie,
strategies focusing on adopting treatment behaviors); to inform
and educate; to support (ie, strategies assisting consumers with
their medicines use such as peer support); to teach skills; to
minimize risk and harms (ie, strategies focusing on preventing
or managing adverse events); to facilitate communication or
decision making; and to improve health care quality (ie,
strategies improving, coordinating, or integrating the delivered
care). Only the adherence outcome at study endpoint was
extracted where magnitude of the intervention effect would be
most apparent. For continuous outcomes Cohen d for assessing
effect size was calculated if means and SDs were provided [22].
Dichotomous outcomes were recalculated to odds ratio (OR)
where OR ≥2.0 is deemed to be a strong OR [23]. Additionally,
if the authors reported a statistical significance favoring the
intervention group compared to the control group, this was
scored positive (+). A negative score (–) means there was no
statistically significant difference to report. Data were extracted
by one researcher (BP) and checked for accuracy by a second
researcher (JV).
Data Analysis
Statistical data pooling was not feasible due to heterogeneity
between studies and interventions. Therefore a best evidence
synthesis was performed to examine the effectiveness of
interactive eHealth interventions on medication adherence. The
Cochrane Back Review Group defines 4 levels of evidence:
strong, moderate, limited, and conflicting evidence [24]. Strong
evidence reflects consistent (ie, 75% or more of the studies
report results in the same direction) results among 2 or more
high quality studies. Moderate evidence reflects consistent
results of 1 high-quality study and 2 or more lower-quality
studies. Limited evidence reflects the result of 1 lower-quality
study. Conflicting evidence reflects inconsistent results among
2 or more studies. If there were 2 or more high-quality studies,
the lower-quality studies were disregarded in the best evidence
synthesis. A post-hoc sensitivity analysis was performed to
examine the robustness of the best evidence synthesis using a
more stringent cut-off score (6 out of 7 instead of 5 out of 7




Figure 1 shows a flow diagram of the literature search which
provided a total of 9047 publications for screening and yielded
21 articles reporting on 29 interactive eHealth interventions
[25-45]. One article, by Reese et al [34], reported on 2 studies.
Five studies reported on more than 1 intervention
[28,34,35,38,45].
Figure 1. PRISMA flow diagram of study search and selection.
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Risk of Bias Assessment
Fifteen studies had a positive score on at least five domains and
were regarded high-quality studies as shown in Figure 2. Two
studies had the lowest score with 2 out of 7 domains scored as
positive.
Figure 2. Summary of risk of bias assessment using the Cochrane Collaboration’s tool for assessing risk of bias.
Description of Study Population
Over half of the studies (13/22) included long-term medication
for cardiovascular disease, diabetes, or both. Seven studies
focused on other, single long-term conditions, leaving 2 studies
that looked at any long-term conditions where long-term
medication was in use.
The smallest study reported on 70 participants at baseline and
the largest study involved 21,752 participants. Because all
studies were randomized, baseline characteristics of the different
groups were generally the same.
Description of Study Design
Follow-up was short (ie, less than 6 months) in 11 studies and
long (at least six months) in 11 studies. The primary medication
adherence outcome of each of the studies was mainly assessed
objectively using medication monitoring devices, pharmacy
prescription data, and serum levels. The remaining 6 studies
measured adherence subjectively with validated self-report
questionnaires (eg, Immunosuppressant Therapy Adherence
Instrument).
Description of eHealth Interventions and Intervention
Strategies
Twenty-nine different interactive eHealth interventions were
evaluated as shown in Table 1. Most (21/29, 72%) interventions
specified using a (mobile) phone for calling, SMS text
messaging, or mobile apps.
Most (25/29) interventions were aimed at the patient, 3
interventions were aimed at the caregiver, and another was
aimed at either patient or caregiver.
Sixteen interventions were provided through automated software
without involvement of a health care professional: 6 mobile
apps, 5 monitoring devices, 3 SMS text messages or IVR
interventions, and 2 e-training modules through an online portal.
Another 7 interventions were provided through automated
software in combination with tele-feedback by a health care
professional or caregiver: 4 monitoring devices, 2 IVR or SMS
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text message interventions, 1 e-training. The 6 remaining
interventions were telephone calls performed by health care
professionals.
Regarding intervention strategies, nearly all (23/29, 79%)
interventions aimed at informing and educating patients and
just over half (15/29, 52%) sought to support patients by
providing assistance and encouragement. All other strategies
(eg, teaching skills, facilitating communication or decision
making) were less frequently applied (see Multimedia Appendix
2).
Effectiveness of eHealth Interventions on Medication
Adherence
Overall, 17 interventions yielded a statistically significant
improvement of medication adherence compared to the control
group (Table 2). For 14 of these interventions an effect size
(Cohen d) could also be calculated; 2 interventions reported a
large effect size (Cohen d ≥ 0.8) [25,29], 4 had a medium effect
size (Cohen d ≥ 0.5 < 0.8) [35,43,45], 3 had a small effect size
(Cohen d ≥ 0.2 < 0.5) [26,32,35], and 5 interventions had a
negligible effect size (Cohen d < 0.2) [27,30,37,38]. For the
remaining 3 interventions an OR could be calculated which
showed strong odds for becoming adherent in the intervention
group (OR ≥ 2.0) [36,39,42].
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Table 1. Characteristics of the eHealth interventions.














Levine et al [28]
Transplant Hero is an interactive alarm to remind
patients to take their medications as well as
providing educational content.
App135038NoneTacrolimus
Transplant Hero (see above) combined with a





Cizmic et al [39]
An IVR call focusing on known reasons for not
initiating therapy. If the medication was not
IVRa4118127NoneBisphosphonates
picked up 7 days after receiving the call, a re-
minder letter was sent.
O’Connor et al [33]
A single-protocol-structured telephone call from
an interventionist using positive reinforcement
and probing for reasons of nonadherence.
Call911581220NoneAntihypertensives or
medication for lowering
blood glucose or choles-
terol
Kessler et al [45]
A wireless pill bottle generated an alert message,
sent to the participant, if medication was missed
Device263451<80%Statins
the previous day and at least once in the 2 prior
days.
A wireless pill bottle generated an automated
alert message (see above), sent to the participant
and a designated caregiver.
Device263446<80%Statins
Márquez Contreras et al
[29]
The AlerHTA app aimed to promote health edu-
cation in hypertension and remind for both ap-
pointments and medication intake time.
App527573NoneAntihypertensives
Montalescot et al [31]
An education program consisting of an education
booklet, one or more reminder tools chosen by
the participant, and access to a telephone clinic.
e-Training24583579NoneApixaban
Reese et al [34]
PROMOTE-1: a wireless pill bottle generated a
weekly adherence report in which the patient’s
adherence was compared to other patients.
Device136767<80%Statins
PROMOTE-2: a wireless pill bottle generated a
weekly adherence report.
Device136767<80%Statins
SUPPORT-1: a wireless pill bottle generated a
daily adherence report.
Device135050<80%Statins
SUPPORT-2: a wireless pill bottle generated a
weekly adherence report.
Device135050<80%Statins
SUPPORT-3: a wireless pill bottle generated an
email alert if the patient missed a dose the previ-
ous day.
Device135050<80%Statins
Reese et al [35]
A wireless pill bottle generated an alert when
medication was due and patients could select
Device264040NoneTacrolimus
additional reminders such as SMS text messages,
calls, or emails.
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A wireless pill bottle generated an alert (see
above). If adherence decreased to <90% in a 14-
day period, the study coordinator would call the
patient and notify the involved HCPsc.
Device264040NoneTacrolimus
Svendsen et al [36]
An app which provided once-daily reminders
and information on number of treatment applica-
tions and amount of prescribed foam applied.
App46668noneCalcipotriol/betametha-
sone foam
Abughosh et al [25]
A brief telephone intervention by pharmacists
to remind the patients of their overdue refill and
to identify potential adherence barriers.
Call269987<80%RASb inhibitors
Abughosh et al [26]
Six motivational interviewing phone calls by
pharmacy students to identify potential adher-
ence barriers and provide guidance to address
these barriers.
Call26495248<80%RAS inhibitors
Choudhry et al [37]
Tailored telephone consultation to develop a
shared plan to improve adherence and disease




blood glucose or choles-
terol
Ducoulombier et al [42]
Bimonthly telephone follow-up to motivate pa-
tients to maintain good adherence, detect diffi-




Kooij et al [27]
Telephone counselling 7-21 days after the start
of therapy assessing practical and perceptual




Vollmer et al [38]
An IVR call when (over)due for a refill provid-
ing patient education and refill support.
IVR5272557247<90%RAS inhibitors and
statins
In addition to IVR calls (see above), a reminder
letter was sent if they were 60-89 days overdue,
a call was made if they were ≥90 days overdue,
and primary care provider informed. Patients
also received a personalized health report, a pill
organizer, and bimonthly mailings.
IVR5272557250<90%RAS inhibitors and
statins
Claborn et al [40]
eLifeSteps: a single-session, self-paced multime-
dia intervention tackling practical and psycho-




Côté et al [41]
Transplant-TAVIE was composed of 3 interac-
tive Web-based sessions by a virtual nurse aimed
at developing and reinforcing self-management
skills required for medication intake.
e-Training263535NoneImmunosuppressants
Kamal et al [43]
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SMS4stroke sent automated customized SMS






Kamal et al [44]
Daily IVR call services, daily prescription-tai-
lored medication reminders, and once weekly




Mira et al [30]
A tablet-based medication self-management app
(ALICE) with medication reminders and medi-
cation information such as pictures, interactions,




Morawski et al [32]
The MediSafe app is a medication reminder app
with additional functions such as adherence re-
ports, tracking of measurements, and peer sup-
port.
App12202209NoneAntihypertensives
aIVR: interactive voice response.
bRAS: renin–angiotensin system.
cHCP: health care professional.
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Table 2. Adherence measure and medication adherence results of the studies reviewed.
Statistically significantaAdherence measure, study, and results on medication adherence
Serum level (0 - 100)
Levine et al [28]
–The coefficient of variability (SD/mean × 100) of tacrolimus levels was 33.0 for the intervention group and
32.8 for the control group (Cohen d = 0.01).
–The coefficient of variability was 33.8 for the intervention group and 32.8 for the control group (Cohen d =
0.07).
Fill first prescription (0 %- 100%)
Cizmic et al [39]
+49% of the intervention group filled their first prescription compared to 31% of the control group (ORb 2.17;
95% CI 1.29-3.67).
–O’Connor et al [33]
–84% of the intervention group filled their first prescription compared to 84% of the control group (OR 0.94;
95% CI 0.79-1.11).
Bottle openings (0%-100%)
Kessler et al [45]
+Average daily adherence was 53% for the intervention group and 36% for the control group (Cohen d = 0.70).
+Average daily adherence was 55% for the intervention group and 36% for the control group (Cohen d = 0.70).
Márquez Contreras et al [29]
+Average daily adherence was 86% for the intervention group and 63% for the control group (Cohen d = 4.72).
Montalescot et al [31]
–Average daily adherence was 92% for the intervention group and 92% for the control group (Cohen d = 0.02).
Reese et al [34]
–Average daily adherence was 77% for the intervention group and 75% for the control group.
–Average daily adherence was 71% for the intervention group and 75% for the control group.
Reese et al [34]
–Average daily adherence was 73% for the intervention group and 79% for the control group.
–Average daily adherence was 75% for the intervention group and 79% for the control group.
–Average daily adherence was 75% for the intervention group and 79% for the control group.
Reese et al [35]
+Average daily adherence (during the final 90 days) was 78% for the intervention group and 55% for the control
group (Cohen d = 0.37).
+Average daily adherence (during final 90 days) was 88% for the intervention group and 55% for the control
group (Cohen d = 0.57).
Svendsen et al [36]
+66% of the intervention group was considered adherent compared to 38% of the control group (OR 3.22; 95%
CI 1.53-6.80).
PDCc,d (0% - 100%)
Abughosh et al [25]
+PDC was 58% for the intervention group and 29% for the control group (Cohen d = 1.32).
Abughosh et al [26]
+PDC was 66% for the intervention group and 57% for the control group (Cohen d = 0.26).
Choudhry et al [37]
+PDC was 46% for the intervention group and 42% for the control group (Cohen d = 0.12).
+Ducoulombier et al [42]
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Statistically significantaAdherence measure, study, and results on medication adherence
+65% of the intervention group was considered adherent compared to 33% of the control group (OR 3.71; 95%
CI 1.94-7.07).
Kooij et al [27]
+PDC was 81% for the intervention group and 76% for the control group (Cohen d = 1.34).
Vollmer et al [38]
+PDC was 58% for the intervention group and 56% for the control group (Cohen d = 2.09).
+PDC was 59% for the intervention group and 56% for the control group (Cohen d = 2.14).
AACTGAIe (0% - 100%)
Claborn et al [40]
–Adherence was 81% for the intervention group and 81% for the control group (Cohen d = –0.03).
ITASf (0-12)
Côté et al [41]
–Mean ITAS score was 11.7 in the intervention group and 11.3 in the control group (Cohen d = 0.30).
MMAS g (0-8)
Kamal et al [43]
+Mean MMAS score was 7.4 in the intervention group and 6.7 in the control group (Cohen d = 0.62).
MMAS (0-8)
Kamal et al [44]
–Mean MMAS score was 7.3 in the intervention group and 7.1 in the control group (Cohen d = 0.03).
MMAS-4 (0-8)
Mira et al [30]
+Mean MMAS score was 7.4 in the intervention group and 7.3 in the control group (Cohen d = 0.12; not cor-
rected for baseline).
MMAS (0-8)
Morawski et al [32]
+Mean MMAS score was 6.3 in the intervention group and 5.7 in the control group (Cohen d = 0.35).
aAs reported by the authors. + indicates P<.05 favoring intervention and – indicates P>.05 (no significant difference between groups).
bOR: odds ratio.
cPDC: percentage of days covered.
dAll PDC outcomes were based on refill data; pill counts were considered separately.
eAACTGAI: Adult AIDS Clinical Trials Group Adherence Instrument.
fITAS: Immunosuppressant Therapy Adherence Instrument.
gMMAS: Morisky Medication Adherence Scale.
Further details of the study, population, intervention, and
outcomes can be found in the extraction database provided as
Multimedia Appendix 5.
The best evidence synthesis (Table 3) showed strong evidence
for a positive effect for SMS text messages or IVR, mobile apps,
and calls as mode of adherence tele-feedback. The evidence for
e-training was weak and for monitoring devices conflicting.
In the post hoc sensitivity analysis the criteria for a high-quality
study were more stringent (6 out of 7 domains graded as low
risk of bias). The sensitivity analysis showed that the strong
evidence for a positive effect for SMS or IVR as mode of
adherence tele-feedback remained, whereas the evidence turned
to conflicting for interventions delivered through mobile apps
and calls (see Multimedia Appendix 3).
The level of evidence of the intervention strategies was also
assessed. There was strong evidence for a positive effect of
strategies to teach skills, to facilitate communication or decision
making, and to improve health care quality. For all other
intervention strategies (eg, to support, to inform and educate)
there was conflicting evidence (see Multimedia Appendix 4).
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Table 3. Results of the best evidence synthesis.
Level of evidenceStatistically significantaMode of adherence tele-feedback and quality
Conflicting evidenceMonitoring device
+, +, +, +, –, –, –, –, –9 HQb interventions
0 LQc interventions
Strong evidence for a positive effectSMS text messaging or IVRd
+, +, +, +, –5 HQ interventions
0 LQ interventions
Strong evidence for a positive effectMobile app
+, +, +3 HQ interventions
+, –, –3 LQ interventions
Strong evidence for a positive effectCall
+, +, +, –4 HQ interventions
+, +2 LQ interventions
Moderate evidence for no effecte-Training
–1 HQ intervention
–, –2 LQ interventions
a+ indicates P<.05 favoring intervention; – indicates P>.05 (no significant difference between groups). In grading the level of evidence low-quality
studies were disregarded when there were 2 or more high-quality studies.
bHQ: high quality.
cLQ: lower quality.
dIVR: interactive voice response.
Discussion
Principal Findings
This systematic review examined the effectiveness of interactive
eHealth interventions to improve medication adherence in
patients using long-term medication published between 2014
and 2019. A majority, 17/29 interactive interventions, had a
statistically significant (P<.05) effect on medication adherence.
There was strong evidence for a positive effect for interventions
using SMS or IVR, mobile apps, and calls as mode of adherence
tele-feedback. Intervention strategies to teach skills, to improve
health care quality, and to facilitate communication or decision
making showed a strong evidence for a positive effect. Overall,
this review shows that interactive eHealth interventions can be
effective in improving medication adherence.
Interactive eHealth Interventions
This study showed strong evidence for a positive effect on
medication adherence of eHealth interventions across various
channels, including SMS, IVR, mobile apps, and calls. Our
findings add robustness to the positive effect of eHealth
interventions provided by previous systematic reviews and
meta-analyses [46-51]. Where those authors were cautious with
interpreting their findings because of low-quality studies, small
sample sizes, and short follow-up, many studies we included
were of high quality (22/29), had sample sizes of 100 patients
or more (19/29), and follow-up of at least six months (14/29).
IVR interventions that included information about health
consequences suggest a stronger behavioral change, including
medication-taking behavior [51]. This review confirms these
findings as the included IVR interventions all contained
information on the consequences of (not) taking medication as
prescribed. For call, mobile app, and SMS text messaging
interventions it remains unclear whether there are intervention
elements (eg, content, intervention design, or extent of tailoring)
that contribute to increased medication adherence because most
eHealth interventions are multicomponent and elements vary
widely across interventions [46,48,50].
We found a lack of convincing evidence for interventions
applying an electronic monitoring device or e-training. By
contrast, van Heuckelum et al [52] found a positive effect for
interventions using monitoring device feedback. In our review
all interventions coupled their electronic monitoring devices to
the same (Way To Health) communication platform which could
be a possible explanation. Yet, van Heuckelum et al [52] also
included interventions that gave face-to-face feedback on
adherence data collected by monitoring devices. They showed
that these interventions were effective, whereas those that
applied tele-feedback were not. This suggests that feedback on
tele-monitoring of medication adherence is best given
face-to-face.
Intervention Strategies
To describe intervention strategies among effective interactive
eHealth interventions we used Lowe’s taxonomy as it is specific
for adherence interventions with clear examples for each
strategy. Although other taxonomies (eg, Abraham and Michie
[53], Demonceau et al [54], Kini and Ho [7]) could have been
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used, they show many conceptual similarities with Lowe’s
taxonomy. Following Lowe’s taxonomy, we provide evidence
for interactive adherence interventions aimed at teaching skills
such as self-management programs, improving health care
quality by coordinating medication adherence care between
professionals, and facilitating communication or decision
making between patient and health care professional. These
results should be interpreted with caution because interventions
were multifaceted and combined different strategies.
Furthermore, the strategies with the highest level of evidence
were also those that were less used. It is not possible to assign
success to a single strategy within a multifaceted intervention.
Nonetheless, the effective strategies we identified in this review
suggest to be good starting points for development or selection
of interventions.
Patient Populations
Noteworthy, the included studies in our review using eHealth
interventions to address medication adherence reflect 2 distinct
patient populations, namely, the large patient population (eg,
metabolic and cardiovascular disease) and the population where
optimal medication adherence is critical (eg,
immunosuppressants, antiretroviral therapy). Applying eHealth
to address medication adherence can be advantageous for both
populations albeit for different reasons. eHealth interventions
can be accessible for large patient populations, giving health
care professionals a large outreach with limited resources. For
populations where optimal medication adherence is critical,
eHealth interventions can be tailored to patients’ specific needs
and provide continuous support.
Study Quality
Where others found a lack of high-quality studies and stressed
the importance of improving study quality [3,9,15], this review
included 15 (out of 23) high-quality studies. The increase in
quality presumably is a direct consequence of better reporting
and study designs. We chose the Cochrane risk of bias tool
(version 1) to assess study quality. This tool focusses on internal
validity and does not cover all aspects of study design. We found
flaws in study design that were not covered by the Cochrane
risk of bias tool such as absence of sample size calculation,
selection bias, and disputable (adherence) outcomes. This could
have (negatively) affected the implications of the results.
Clinical Implications and Future Research
We clustered evidence of various long-term conditions in our
best evidence synthesis to provide a comprehensive overview.
This overview is based on the statistically significant effects
(P<.05) found by the authors and supported by the effect sizes
we calculated. Of the 17 statistically significant (P<.05)
interventions, 9 showed at least a small effect size (Cohen d ≥
0.2) and 3 interventions showed strong odds (OR > 2.0) for
effect in the intervention group.
The synthesis was limited to medication adherence and did not
consider other clinical outcomes. As a result, our findings may
not be applicable one-on-one to specific conditions. Next step
is to study the identified effective interventions/strategies in
specific long-term conditions to ascertain that this may lead to
improved medication adherence and other clinical outcomes.
Only postintervention effectiveness on medication adherence
was assessed in this review. Whether the found beneficial effects
will be maintained over a longer period (>12 months) remains
unclear. However, 12/17 effective interventions in our review
had a follow-up of at least six months which is considered the
shortest period to accurately assess long-term medication
adherence [4].
We were surprised to find many interactive eHealth
interventions that use technologies published in the 20th century.
Although technology changes, applied techniques are very
similar. To be able to build upon data and lessons learnt from
older technologies, crosslinks between similar techniques need
to be made (eg, between SMS text messaging and chat services
such as WhatsApp or WeChat).
Technological developments are very fast paced and eHealth
interventions continuously change. This high turnaround speed
creates a need for study designs that allow continuous evaluation
of interventions over a period of at least six months.
In this review intervention exposure ranged from a single call
to daily messages for months. To establish a relation between
exposure and medication taking behavior change, dose–response
studies are called for.
Conclusion
We found that a majority of interactive eHealth interventions
are effective in improving adherence to long-term medication.
Intervention strategies that improve patient’s treatment
involvement and their medication management skills are most
promising. While most interactive eHealth interventions were
multifaceted, even simple eHealth technologies such as SMS
text messaging and telephone calls can be effective in promoting
medication adherence in a wide variety of patient populations.
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